Previous Close | 106.87 |
Open | 106.21 |
Bid | 105.00 x 900 |
Ask | 105.59 x 1100 |
Day's Range | 105.11 - 106.68 |
52 Week Range | 72.88 - 115.49 |
Volume | |
Avg. Volume | 9,162,377 |
Market Cap | 267.18B |
Beta (5Y Monthly) | 0.39 |
PE Ratio (TTM) | 17.48 |
EPS (TTM) | 6.03 |
Earnings Date | Feb 02, 2023 |
Forward Dividend & Yield | 2.92 (2.77%) |
Ex-Dividend Date | Mar 14, 2023 |
1y Target Est | 116.96 |
Subscribe to Yahoo Finance Plus to view Fair Value for MRK
Merck & Co., Inc. ( NYSE:MRK ) will increase its dividend from last year's comparable payment on the 10th of April to...
RAHWAY, N.J., January 27, 2023--FDA Approves KEYTRUDA as Adjuvant Treatment Following Surgical Resection and Chemotherapy for Patients With Stage IB (T2a ≥4 cm), II, or IIIA NSCLC
Merck (MRK) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.